• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗法动员和 G-CSF 给药在成功造血干细胞采集中的协同作用。

Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.

机构信息

Department of Medicine V, Heidelberg University, Heidelberg, Germany.

Institute of Pathology, Heidelberg University, Heidelberg, Germany.

出版信息

Biol Blood Marrow Transplant. 2018 Jun;24(6):1281-1288. doi: 10.1016/j.bbmt.2018.01.007. Epub 2018 Jan 17.

DOI:10.1016/j.bbmt.2018.01.007
PMID:29353110
Abstract

Successful collection of peripheral blood stem cells (PBSCs) depends on the optimal orchestration of mobilization chemotherapy, granulocyte colony stimulating factor (G-CSF) application, and CD34 cell number assessment in the peripheral blood (PB). However, determining the optimal timing in accordance to the applied chemomobilization regimen can be challenging. Although most centers apply their own local timing schedules, a reliable timetable including the currently most often used mobilization regimens is lacking. We present a comprehensive analysis of the timing modalities for 11 of the most commonly used chemomobilization regimens. A retrospective analysis was performed on the clinical and PBSC collection parameters (including duration of G-CSF application, time point of CD34 assessment, PB CD34 cell count, number of leukapheresis [LP] sessions, processed blood volume, and CD34 collection results) of 91 representatively selected patients who had undergone stem cell mobilization at 2 collection centers. Six to 10 patients were analyzed per regimen with a variety of diagnoses, including multiple myeloma, malignant lymphoma, and sarcoma. No collection failures (<2 × 10 CD34 cells/kg body weight) were observed. All analyzed patients successfully reached their individual collection goal in adherence to the given schedule of chemotherapy, application of G-CSF, measurement of CD34 cells, and subsequent LP. The presented data on the timing of chemomobilization, G-CSF application, and stem cell collection may be helpful in clinical decision making and contribute to a more transparent and predictable treatment process.

摘要

成功采集外周血干细胞 (PBSC) 取决于动员化疗、粒细胞集落刺激因子 (G-CSF) 应用和外周血 (PB) 中 CD34 细胞数量评估的最佳协调。然而,根据所应用的化学动员方案确定最佳时机可能具有挑战性。尽管大多数中心都采用自己的本地时间表,但缺乏包括当前最常用的动员方案在内的可靠时间表。我们对 11 种最常用的化学动员方案的时间模式进行了全面分析。对在 2 个采集中心进行干细胞动员的 91 名代表性选择患者的临床和 PBSC 采集参数(包括 G-CSF 应用持续时间、CD34 评估时间点、PB CD34 细胞计数、白细胞分离术 [LP] 次数、处理的血液量和 CD34 采集结果)进行了回顾性分析。每个方案分析了 6 到 10 名具有多种诊断的患者,包括多发性骨髓瘤、恶性淋巴瘤和肉瘤。未观察到采集失败 (<2 × 10 CD34 细胞/kg 体重)。所有分析的患者均成功按照化疗、G-CSF 应用、CD34 细胞测量和随后的 LP 时间表达到各自的采集目标。关于化学动员、G-CSF 应用和干细胞采集时间的提供的数据可能有助于临床决策,并有助于更透明和可预测的治疗过程。

相似文献

1
Orchestration of Chemomobilization and G-CSF Administration for Successful Hematopoietic Stem Cell Collection.化疗法动员和 G-CSF 给药在成功造血干细胞采集中的协同作用。
Biol Blood Marrow Transplant. 2018 Jun;24(6):1281-1288. doi: 10.1016/j.bbmt.2018.01.007. Epub 2018 Jan 17.
2
Mobilization and Collection of Peripheral Blood Stem Cells in Adults: Focus on Timing and Benchmarking.成人外周血干细胞的动员与采集:关注时机与基准
Methods Mol Biol. 2019;2017:41-58. doi: 10.1007/978-1-4939-9574-5_4.
3
Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.使用化疗联合或不联合系统性粒细胞集落刺激因子(G-CSF)进行造血干细胞采集:52例多发性骨髓瘤患者的经验
Bone Marrow Transplant. 1999 Sep;24(5):463-6. doi: 10.1038/sj.bmt.1701910.
4
Predictors for successful PBSC collection on the fourth day of G-CSF-induced mobilization in allogeneic stem cell donors.异基因干细胞供者在粒细胞集落刺激因子诱导动员第4天成功采集外周血干细胞的预测因素。
J Clin Apher. 2017 Dec;32(6):397-404. doi: 10.1002/jca.21528. Epub 2017 Jan 31.
5
Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.对225例接受自体移植的患者采用中剂量环磷酰胺、序贯应用粒细胞巨噬细胞集落刺激因子和粒细胞集落刺激因子进行外周血祖细胞动员,并安排开始白细胞分离术。
Transfusion. 2007 Nov;47(11):2153-60. doi: 10.1111/j.1537-2995.2007.01440.x.
6
Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.生物类似药非格司亭、原研非格司亭和来格司亭在多发性骨髓瘤患者自体干细胞动员中的比较。
Transfusion. 2017 Oct;57(10):2359-2365. doi: 10.1111/trf.14211. Epub 2017 Jun 26.
7
Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients.比较不同干细胞动员方案在 AL 淀粉样变性患者中的疗效。
Biol Blood Marrow Transplant. 2017 Nov;23(11):1870-1878. doi: 10.1016/j.bbmt.2017.07.015. Epub 2017 Jul 25.
8
Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma.基于顺铂的改良动员化疗后弥漫性大B细胞淋巴瘤患者的高效干细胞采集
Biol Blood Marrow Transplant. 2016 Aug;22(8):1397-1402. doi: 10.1016/j.bbmt.2016.03.030. Epub 2016 Apr 7.
9
GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.基于粒细胞巨噬细胞集落刺激因子的动员效应在正常健康供者用于异基因外周血干细胞移植中的作用
Bone Marrow Transplant. 2002 Jul;30(2):81-6. doi: 10.1038/sj.bmt.1703598.
10
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.祖细胞动员的随机交叉试验:大剂量环磷酰胺加粒细胞集落刺激因子(G-CSF)与粒细胞巨噬细胞集落刺激因子加G-CSF的比较
J Clin Oncol. 2000 May;18(9):1824-30. doi: 10.1200/JCO.2000.18.9.1824.

引用本文的文献

1
[Chinese consensus on autologous stem cell transplantation for adult acute leukemia (2024)].《成人急性白血病自体造血干细胞移植中国专家共识(2024年版)》
Zhonghua Xue Ye Xue Za Zhi. 2024 Jul 14;45(7):637-644. doi: 10.3760/cma.j.cn121090-20240611-00218.
2
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.来那度胺、硼替佐米和地塞米松联合依鲁替尼或伊沙妥昔单抗治疗初诊多发性骨髓瘤患者后的干细胞采集:来自 GMMG-HD6 和 -HD7 试验的单中心经验。
BMC Cancer. 2023 Nov 21;23(1):1132. doi: 10.1186/s12885-023-11507-9.
3
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.
临床参数和诱导方案对多发性骨髓瘤患者外周血干细胞动员及采集的影响
Transfus Med Hemother. 2023 Jun 5;50(5):382-395. doi: 10.1159/000530056. eCollection 2023 Oct.
4
Flow Cytometric Characterization of Hematopoietic Stem and Progenitor Cell Subpopulations in Autologous Peripheral Blood Stem Cell Preparations after Cryopreservation.冷冻保存后自体外周血干细胞制品中造血干细胞和祖细胞亚群的流式细胞术特征分析
Transfus Med Hemother. 2023 Sep 15;50(5):417-427. doi: 10.1159/000533624. eCollection 2023 Oct.
5
The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphoma.高复发风险/高危 IV 期弥漫性大 B 细胞淋巴瘤患者进行 upfront 自体干细胞移植的意义。
Cancer Rep (Hoboken). 2023 Apr;6(4):e1786. doi: 10.1002/cnr2.1786. Epub 2023 Feb 28.
6
Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.多发性骨髓瘤患者干细胞动员失败的危险因素及结局
Transfus Med Hemother. 2022 Sep 5;50(1):39-50. doi: 10.1159/000525565. eCollection 2023 Feb.
7
Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors.支持大剂量化疗的造血干细胞动员策略:聚焦复发/难治性生殖细胞肿瘤
World J Clin Oncol. 2021 Sep 24;12(9):746-766. doi: 10.5306/wjco.v12.i9.746.
8
[Consensus of Chinese experts on the mobilization and collection of autologous hematopoietic stem cells in lymphoma (2020)].《中国淋巴瘤自体造血干细胞动员与采集专家共识(2020年版)》
Zhonghua Xue Ye Xue Za Zhi. 2020 Dec 14;41(12):979-983. doi: 10.3760/cma.j.issn.0253-2727.2020.12.002.